UK Markets close in 6 hrs 12 mins
  • FTSE 100

    7,474.31
    -80.00 (-1.06%)
     
  • FTSE 250

    21,667.41
    -187.16 (-0.86%)
     
  • AIM

    1,081.99
    -4.65 (-0.43%)
     
  • GBP/EUR

    1.2011
    +0.0009 (+0.07%)
     
  • GBP/USD

    1.3377
    -0.0005 (-0.0348%)
     
  • BTC-GBP

    27,302.24
    -198.17 (-0.72%)
     
  • CMC Crypto 200

    827.54
    +8.04 (+0.98%)
     
  • S&P 500

    4,326.51
    -23.42 (-0.54%)
     
  • DOW

    34,160.78
    -7.31 (-0.02%)
     
  • CRUDE OIL

    86.94
    +0.33 (+0.38%)
     
  • GOLD FUTURES

    1,791.90
    -3.10 (-0.17%)
     
  • NIKKEI 225

    26,717.34
    +547.04 (+2.09%)
     
  • HANG SENG

    23,550.08
    -256.92 (-1.08%)
     
  • DAX

    15,271.00
    -253.27 (-1.63%)
     
  • CAC 40

    6,927.79
    -96.01 (-1.37%)
     

Global Endocrine Testing Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

·4-min read

DUBLIN, December 01, 2021--(BUSINESS WIRE)--The "Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, the publisher expects the market to grow at a CAGR of 8.7% during 2021-2026.

Companies Mentioned

  • Abbott Laboratories

  • Agilent Technologies Inc.

  • Bio-Rad Laboratories Inc.

  • BioMerieux SA

  • DiaSorin S.p.A.

  • F. Hoffmann-La Roche AG (Roche Holding AG)

  • Laboratory Corporation of America Holdings

  • Quest Diagnostics Incorporated

  • Siemens Healthineers AG (Siemens Aktiengesellschaft)

  • Thermo Fisher Scientific Inc.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor.

Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Questions Answered in This Report:

  • How has the global endocrine testing market performed so far and how will it perform in the coming years?

  • What has been the impact of COVID-19 on the global endocrine testing market?

  • What are the key regional markets?

  • What is the breakup of the market based on the test type?

  • What is the breakup of the market based on the technology?

  • What is the breakup of the market based on the end use?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the industry?

  • What is the structure of the global endocrine testing market and who are the key players?

  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Endocrine Testing Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Test Type

7 Market Breakup by Technology

8 Market Breakup by End Use

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/1w2wcs

View source version on businesswire.com: https://www.businesswire.com/news/home/20211201005485/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting